Back
Braveheart Bio, Inc. BRVE · Insights
Braveheart Bio, Inc. engages in the development of therapeutics to treat hypertrophic cardiomyopathy... Price19.46
Market Cap1.37 B
Float...
CountryUS
SectorHealthcare
ExchangeNASDAQ
OverviewFilingsInsightsDilutionNewsTranscriptsInsights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro Insights are a pro only featureUpgrade now to access key point-in-time insights for this ticker. We have shown an example insight below.Upgrade to Pro